NCT05940584 Tele-reha Versus Paper-based Aftercare Programme Following Inpatient Rehabilitation
| NCT ID | NCT05940584 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | Neurologic Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 285 participants |
| Start Date | 2023-07-14 |
| Primary Completion | 2025-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 285 participants in total. It began in 2023-07-14 with a primary completion date of 2025-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this three-armed, observer-blinded, randomised controlled trial is to (i) to implement a telerehabilitation intervention in routine care after an inpatient rehabilitation stay for people insured with the Social Insurance Institution for the Self-Employed (SVS), (ii) to evaluate the impact of telerehabilitation on the consolidation of goals achieved during the inpatient stay in everyday life, and (iii) to evaluate whether independence in everyday life can be increased by implementing telerehabilitation at home compared to standard care. Our hypothesis is that the tele-reha intervention, including ongoing therapist support, will improve independence in daily living (defined as the primary outcome of this study), as measured by the Functional Assessment Measure (FAM), compared to a control group receiving a standard paper-based program.
Eligibility Criteria
Inclusion Criteria: * aged 18 years or older, * experiencing problems with motor function, sensory function, cognition, swallowing or speech production (regardless of their diagnosis), * being insured with SVS, * agreeing to telerehabilitation after discharge, * having sufficient motor and cognitive abilities to operate a smartphone, tablet or PC, or being sufficiently supported by caregivers, and * being able to independently perform the targeted tasks assigned to them. Exclusion Criteria: \- pronounced impairments in awareness, memory, attention, spatial performance, executive performance, apraxia, speech, and visual perception that do not allow a safe study participation according to the treating physicians or therapists
Frequently Asked Questions
Who can join the NCT05940584 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Neurologic Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05940584 currently recruiting?
Yes, NCT05940584 is actively recruiting participants. Visit ClinicalTrials.gov or contact Medical University of Vienna to inquire about joining.
Where is the NCT05940584 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT05940584 clinical trial?
NCT05940584 is sponsored by Medical University of Vienna. The trial plans to enroll 285 participants.